5月26日电，利弗莫尔证券显示，北京先通国际医药科技股份有限公司-B向港交所提交上市申请书，联席保荐人为中信证券、中金公司。

Group 1 - The core point of the article is that Beijing Xiantong International Pharmaceutical Technology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange [1] - The joint sponsors for the listing are CITIC Securities and China International Capital Corporation [1]